However, there was increased angiogenesis in tumors treated with UN-T and H9 CAR T cells, likely due to larger tumor sizes at later time points, obviating earlier observed differences in angiogenesis between groups; the reduction or even loss of IL-15 in recurrent tumors may not have maintained the differences in angiogenesis. Here, IL15 is linked to neoplasm.